Muharrem Muftuoglu
5PUBLICATIONS
52CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|May 06, 2025
Synergistic Activity of Combined FLT3-ITD and MDM2 Inhibition with Quizartinib and Milademetan in FLT3-ITD Mutant/TP53 Wild-type Acute Myeloid Leukemias.Weiguo Zhang, Li Li, Muharrem Muftuoglu
|Apr 04, 2025
CLL cell-derived exosomes alter the immune and hematopoietic systems.Ivo Veletic, David M Harris, Uri Rozovski
|Nov 29, 2023
Enhanced TP53 reactivation disrupts MYC transcriptional program and overcomes venetoclax resistance in acute myeloid leukemias.Yuki Nishida, Jo Ishizawa, Edward Ayoub
|Apr 28, 2022
Author Correction: Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy.Irene Ganan-Gomez, Hui Yang, Feiyang Ma
|Mar 04, 2022
Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy.Irene Ganan-Gomez, Hui Yang, Feiyang Ma
Pageof 1
Frequent Collaborators
4 joint publications
Michael Andreeff
3 joint publications
Koichi Takahashi
2 joint publications
Irene Ganan-Gomez
2 joint publications
Feiyang Ma
2 joint publications
Kelly Chien
2 joint publications
Ganiraju Manyam
2 joint publications
Caleb Class
2 joint publications
Rashmi Kanagal-Shamanna
2 joint publications
Sarah Schneider
2 joint publications
Vera Adema
